Report Categories
View AllRecent Articles
View All
Is First Mid Fmbh Stock In A Selling Zone Price At 41.65 Up 0.39 20260402
Is Pgim High Isd Stock In An Uptrend Price At 13.13 Down 0.30 20260413
Is Horace Hmn Stock Good For Passive Investors Price At 43.48 Up 0.61 20260406
What Do Forecasts Say About Ryman Rhp Stock Rhp Q4 Earnings Misses Estimates By 0.11 20260408 1
SXI Standex International Corporation reports Q1 2026 EPS beat and 96 YoY revenue growth but shares drop 102
When NetScout Systems NTCT Stock Will Fall Institutional Demand 20260418
Gladstone LANDO Stock Analysis Buy or Sell Q4 2025 EPS Misses Views
abrdn IAF Stock Volume Deceleration Market Focus 20260418
Is Autolus AUTL building a durable competitive moat Rallies 20260511
Gabelli GABH Stock Outlook and Forecast GABH Earnings Gabelli Ser H Pfd Lacks Earnings Revenue Reporting
Is ServiceNow NOW stock showing steady movement Tick Up 20260420
VSee Health VSEE Stock Growth vs Risks Edges Lower 20260420
NIE Virtus emphasizes steady convertible income portfolio resilience in its latest quarterly earnings report
Geopolitical Tensions Rise Israeli Strikes in Southern Lebanon Claim 22 Lives Regional Markets on Alert
Technical Assessment Points to Bullish IntermediateTerm Outlook for Equities
Ryan Cohen Urges eBay Board to Engage on Activist Proposal
Consumer Sentiment Remains Subdued Persistent Pessimism Weighs on Economic Outlook
Oculis OCS Q1 2026 Earnings Miss EPS 049 vs 042 Expected
WSFS WSFS Crushes Q1 2026 Estimates EPS 168 Tops Views
TruGolf Holdings TRUG Slides 793 as Selling Pressure Mounts 20260519
Franklin Res BEN Q1 2026 Earnings Why the Beat Matters
Trump Departs Beijing After Strategic Talks on Trade Oil and Taiwan
Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms
Methode Electronics MEI Q1 2026 Earnings Miss Sparks Concern
XCUR Q2 2022 Earnings WiderthanExpected Loss Highlights Challenges for PreRevenue Biotech
AAON Inc Stock Retreats from Resistance Testing Key Support Levels
Roper Technologies ROP Edges Lower Amid Consolidation Key Levels in Focus
Haemonetics HAE Slips Modestly as Stock Tests Support Near 63
ECARX Holdings ECX Faces Continued Pressure Near 100 Level